MentionFox
Home › funding signals › Synkrino Biotherapeutics
Accelerator · announced

Synkrino Biotherapeutics (YC S18) — Synkrino's AI, SATIS is a powerful, unbiased discovery system for…

Synkrino Biotherapeutics appears in Y Combinator's company directory in the Summer 2018 batch, listed 2018-05-16. Synkrino's AI, SATIS is a powerful, unbiased discovery system for….

Just raised? Share it.

Synkrino Biotherapeutics: Accepted into Y Combinator Summer 2018

What do you want to do with Synkrino Biotherapeutics?

Synkrino Biotherapeutics

New accelerator entry · 2018-05-16 · the record

Summer 2018
batch
2
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSummer 2018
Announced2018-05-16
StageEarly
StatusActive
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Drug Discovery and Delivery
SectorsAI-powered Drug Discovery, Biotech
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA; Oakland, CA, USA
HiringNo
Sitehttp://www.synkrino.bio
Previously known asSF17 Therapeutics

The full profile

Checking your access…

Is this you?

If you're behind Synkrino Biotherapeutics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

Tools for this story

Each opens in a new tab, filled in for Synkrino Biotherapeutics. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-synkrino-biotherapeutics
Last updated 2026-09-26
Primary record: Y Combinator directory entry
Synkrino Biotherapeutics (YC S18) — Synkrino's AI, SATIS is a powerful, unbiased discovery system for…. MentionFox, 2026-09-26. https://mentionfox.com/funding/yc-synkrino-biotherapeutics